Filing Details

Accession Number:
0001209191-21-065439
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-11-18 16:08:44
Reporting Period:
2021-11-16
Accepted Time:
2021-11-18 16:08:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1438533 Travere Therapeutics Inc. TVTX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1221599 Steve Aselage C/O Travere Therapeutics, Inc.
3611 Valley Centre Dr., Suite 300
San Diego CA 92130
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-11-16 31,800 $29.39 149,494 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to an automatic trading plan adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.05 to $29.70, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
  3. Includes 19,500 shares previously reported as indirectly held in the name of the Aselage Family Trust.